These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31140669)

  • 1. The role of evidence in consumer choice of non-prescription medicines.
    Bevan M; Ng YC; Cooper J; Robertson J; Walkom E; Chiu S; Newby DA
    Int J Pharm Pract; 2019 Dec; 27(6):501-509. PubMed ID: 31140669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining consumer purchase intentions of non-prescription medicines in supermarkets and community pharmacies.
    Mortimer G; Grimmer L; Fazal-E-Hasan SM
    Int J Pharm Pract; 2019 Jun; 27(3):232-240. PubMed ID: 30431196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public's views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: a cross-sectional questionnaire study.
    Hanna LA; Hughes CM
    Patient Educ Couns; 2011 Jun; 83(3):345-51. PubMed ID: 21440405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumers' self-reported adherence to directions for non-prescription medicines and the role of risk perception.
    Vong SK; Kang L; Carter SR
    Res Social Adm Pharm; 2022 Nov; 18(11):3929-3938. PubMed ID: 35729055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Customers' perceptions of and satisfaction with medicine retail outlet services in Addis Ababa, Ethiopia: a cross-sectional study.
    Gebregeorgise DT; Mohammed TA; Redi ZS; Sporrong SK
    Int J Pharm Pract; 2018 Jun; 26(3):222-231. PubMed ID: 28737242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peculiarity of consumer preference shaping in pharmaceutical market in azerbaijan].
    Mansurova L
    Georgian Med News; 2011 Jan; (190):56-60. PubMed ID: 21346269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opinion of community pharmacists on use of nonprescription medications in Alexandria, Egypt.
    Elhoseeny TA; Ibrahem SZ; Abo el Ela AM
    J Egypt Public Health Assoc; 2013 Aug; 88(2):79-84. PubMed ID: 23963086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian pharmacists: ready for increased non-prescription medicines reclassification.
    Hope DL; Woods P; Mey A; Kelly FS; Townshend J; Baumann-Birkbeck LM; King MA
    Int J Pharm Pract; 2020 Jun; 28(3):246-254. PubMed ID: 31913550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2017; 13(3):476-484. PubMed ID: 27423784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2018 May; 14(5):464-470. PubMed ID: 28624292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public risk perception of non-prescription medicines and information disclosure during consultations: a suitable target for intervention?
    Fielding S; Slovic P; Johnston M; Lee AJ; Bond CM; Watson MC
    Int J Pharm Pract; 2018 Oct; 26(5):423-432. PubMed ID: 29318694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer internet purchasing of medicines using a population sample: A mixed methodology approach.
    Bowman C; Family H; Agius-Muscat H; Cordina M; Sutton J
    Res Social Adm Pharm; 2020 Jun; 16(6):819-827. PubMed ID: 31668549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy patronage: identifying key factors in the decision making process using the determinant attribute approach.
    Franic DM; Haddock SM; Tucker LT; Wooten N
    J Am Pharm Assoc (2003); 2008; 48(1):71-85. PubMed ID: 18192134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.